Side-by-side comparison of AI visibility scores, market position, and capabilities
Westlake OH precision dispensing technology (NASDAQ: NDSN) at record $2.7B FY2024 revenue; semiconductor packaging, medical fluid solutions, and packaging adhesives competing with Graco and ITW for precision manufacturing equipment.
Nordson Corporation is a Westlake, Ohio-based precision dispensing and fluid management technology company — publicly traded on NASDAQ (NASDAQ: NDSN) as an S&P 500 Industrials component — designing and manufacturing equipment for precise application of adhesives, sealants, coatings, biomaterials, and other fluids across electronics assembly, packaging, medical devices, automotive, and industrial manufacturing through approximately 7,500 employees in 35+ countries. In fiscal year 2024, Nordson reported record revenues of $2.7 billion (up 2% year-over-year), net income of $467 million ($8.11 EPS), adjusted EPS of $9.73, with Q4 sales of $744 million (+4%). Nordson guided FY2025 revenue of $2.75-$2.87 billion and adjusted EPS of $9.70-$10.50. Founded in 1954 in Amherst, Ohio by brothers Eric and Evan Nord (whose father Walter Nord had acquired the predecessor company from bankruptcy in 1935), Nordson grew from its origins in airless spray equipment into a Fortune 1000 precision technology leader through 50+ acquisitions. CEO Sundaram "Naga" Nagarajan has led the company since August 2019. Nordson operates through three segments: Industrial Precision Solutions (adhesive and sealant dispensing for packaging, wood assembly, and product manufacturing), Medical and Fluid Solutions (fluid control, single-use biomaterial dispensing, minimally invasive surgical device components), and Advanced Technology Solutions (semiconductor packaging, PCB assembly, and electronics fluid dispensing).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.